Haemodynamic Profile of Patients with End-Stage Liver Disease.

Publikation: Bidrag til bog/antologi/rapportBidrag til bog/antologiFormidling

Standard

Haemodynamic Profile of Patients with End-Stage Liver Disease. / Møller, Søren; Henriksen, Jens Henrik Sahl.

Cardiovascular Diseases And Liver Transplantation. 2011. s. 1-30.

Publikation: Bidrag til bog/antologi/rapportBidrag til bog/antologiFormidling

Harvard

Møller, S & Henriksen, JHS 2011, Haemodynamic Profile of Patients with End-Stage Liver Disease. i Cardiovascular Diseases And Liver Transplantation. s. 1-30.

APA

Møller, S., & Henriksen, J. H. S. (2011). Haemodynamic Profile of Patients with End-Stage Liver Disease. I Cardiovascular Diseases And Liver Transplantation (s. 1-30)

Vancouver

Møller S, Henriksen JHS. Haemodynamic Profile of Patients with End-Stage Liver Disease. I Cardiovascular Diseases And Liver Transplantation. 2011. s. 1-30

Author

Møller, Søren ; Henriksen, Jens Henrik Sahl. / Haemodynamic Profile of Patients with End-Stage Liver Disease. Cardiovascular Diseases And Liver Transplantation. 2011. s. 1-30

Bibtex

@inbook{91238045525446d5bc9e93f910abe711,
title = "Haemodynamic Profile of Patients with End-Stage Liver Disease.",
abstract = "Patients with cirrhosis and portal hypertension exhibit characteristic haemodynamic changes. A vasodilatatory state and a hyperdynamic circulation affect various functions, resulting in multi-organ failure. Thus, the circulation of the lungs, kidneys, brain, gastrointestinal tract and periphery is disturbed. The recently defined cirrhotic cardiomyopathy affects systolic and diastolic functions of the heart and implies electromechanical abnormalities. In addition, baroreceptor response and regulation of circulatory homoeostasis are impaired, and reduced cardiac reserve may also play a role in the development of hepatorenal syndrome. Pulmonary dysfunction involves diffusing abnormalities, with development of hepatopulmonary syndrome and portopulmonary hypertension in some patients with cirrhosis. Recent research has focused on the assertion that haemodynamic and neurohumoral dysregulation are of major importance for the development of many of the organ-related complications in cirrhosis. This aspect is important to take into account in the management of these patients. ",
author = "S{\o}ren M{\o}ller and Henriksen, {Jens Henrik Sahl}",
year = "2011",
language = "English",
pages = "1--30",
booktitle = "Cardiovascular Diseases And Liver Transplantation",

}

RIS

TY - CHAP

T1 - Haemodynamic Profile of Patients with End-Stage Liver Disease.

AU - Møller, Søren

AU - Henriksen, Jens Henrik Sahl

PY - 2011

Y1 - 2011

N2 - Patients with cirrhosis and portal hypertension exhibit characteristic haemodynamic changes. A vasodilatatory state and a hyperdynamic circulation affect various functions, resulting in multi-organ failure. Thus, the circulation of the lungs, kidneys, brain, gastrointestinal tract and periphery is disturbed. The recently defined cirrhotic cardiomyopathy affects systolic and diastolic functions of the heart and implies electromechanical abnormalities. In addition, baroreceptor response and regulation of circulatory homoeostasis are impaired, and reduced cardiac reserve may also play a role in the development of hepatorenal syndrome. Pulmonary dysfunction involves diffusing abnormalities, with development of hepatopulmonary syndrome and portopulmonary hypertension in some patients with cirrhosis. Recent research has focused on the assertion that haemodynamic and neurohumoral dysregulation are of major importance for the development of many of the organ-related complications in cirrhosis. This aspect is important to take into account in the management of these patients.

AB - Patients with cirrhosis and portal hypertension exhibit characteristic haemodynamic changes. A vasodilatatory state and a hyperdynamic circulation affect various functions, resulting in multi-organ failure. Thus, the circulation of the lungs, kidneys, brain, gastrointestinal tract and periphery is disturbed. The recently defined cirrhotic cardiomyopathy affects systolic and diastolic functions of the heart and implies electromechanical abnormalities. In addition, baroreceptor response and regulation of circulatory homoeostasis are impaired, and reduced cardiac reserve may also play a role in the development of hepatorenal syndrome. Pulmonary dysfunction involves diffusing abnormalities, with development of hepatopulmonary syndrome and portopulmonary hypertension in some patients with cirrhosis. Recent research has focused on the assertion that haemodynamic and neurohumoral dysregulation are of major importance for the development of many of the organ-related complications in cirrhosis. This aspect is important to take into account in the management of these patients.

M3 - Book chapter

SP - 1

EP - 30

BT - Cardiovascular Diseases And Liver Transplantation

ER -

ID: 37731984